BRIAN H DOVEY
CIK 1207786 · last filed 2019-11-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.63M
Companies
24
Total Filings
98
Lifetime Open-Market Net
$97.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGOU) Delisted | 10%+ Owner | 591,184 | — | — | $551.2K | 1 | 2018-08-27 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | Director | 298,755 | — | — | $24.29M | 23 | 2017-07-18 |
| Vyome Holdings, Inc (OBLN) Delisted | 10%+ Owner | 16,523 | $9.15 | $151.2K | $0 | 1 | 2016-10-14 |
| GKOS | 10%+ Owner | 6,501 | $179.16 | $1.16M | $0 | 2 | 2015-07-01 |
| OTONOMY, INC. (OTIC) Delisted | Director | 1,628,262 | $0.08 | $125.4K | $0 | 2 | 2015-05-29 |
| Evofem Biosciences, Inc. (NEOT) Delisted | 10%+ Owner | 515,274 | — | — | $6.86M | 1 | 2014-11-26 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 33,890 | — | — | $0 | 1 | 2014-03-17 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 13,004 | $38.22 | $497.0K | $0 | 1 | 2014-02-04 |
| TNDM | 10%+ Owner | 318,906 | $20.25 | $6.46M | $0 | 1 | 2013-11-19 |
| VCYT | 10%+ Owner | 22,730 | $44.59 | $1.01M | $0 | 1 | 2013-11-04 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 19,006 | — | — | $0 | 1 | 2013-09-30 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | 10%+ Owner | 47,835 | — | — | $3.00M | 1 | 2013-08-28 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 7,333 | — | — | $8.00M | 1 | 2013-07-16 |
| Esperion Therapeutics, Inc. (ESPR) Delisted | 10%+ Owner | 1,786,012 | $3.18 | $5.68M | $4.00M | 1 | 2013-07-02 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 534,497 | $5.54 | $2.96M | $3.62M | 5 | 2013-06-24 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 5,130,007 | — | — | $15.68M | 10 | 2013-04-10 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 5,772,968 | — | — | $0 | 3 | 2013-01-18 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 3,006,132 | — | — | $7.06M | 1 | 2012-07-24 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 1,704,080 | $0.08 | $138.4K | $12.11M | 1 | 2011-11-21 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 21,156 | $26.68 | $564.4K | $16.40M | 2 | 2011-09-20 |
| NEOSE TECHNOLOGIES INC (NTEC) Delisted | Director | 167,442 | $9.63 | $1.61M | $0 | 3 | 2009-02-11 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | 10%+ Owner | 3,115,960 | — | — | -$514.6K | 3 | 2009-01-30 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 90,973 | — | — | -$3.27M | 15 | 2008-07-28 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 24,665 | — | — | $0 | 1 | 2007-04-03 |
Recent Filings · Page 2 of 10
98 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-07-14 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-27 | — | Grant (A) | +10,000 | $0 | |
| 2015-07-01 | GKOS | Conv (C) | +45,507 | $0 | EDGAR |
| 2015-07-01 | GKOS | Conv (C) | +70,205 | $0 | EDGAR |
| 2015-06-10 | Orexigen Therapeutics, Inc. (OREX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-29 | OTONOMY, INC. (OTIC) Delisted | Other (J) | −217,255 | $0 | EDGAR |
| 2015-05-29 | — | Grant (A) | +15,000 | $0 | |
| 2014-11-26 | Evofem Biosciences, Inc. (NEOT) Delisted | Mixed | +21,641,494 | $6.86M | EDGAR |
| 2014-08-18 | OTONOMY, INC. (OTIC) Delisted | Mixed | +11,055,261 | -$123 | EDGAR |
| 2014-03-21 | — | Disp (D) | −10,442,531 | -$146.20M |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.